Cargando…
Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
BACKGROUND: The unfolded protein response (UPR) served as a vital role in the progression of tumors, but the molecule mechanisms of UPR in bladder cancer (BLCA) have been not fully investigated. METHODS: We identified differentially expressed unfolded protein response-related genes (UPRRGs) between...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686253/ https://www.ncbi.nlm.nih.gov/pubmed/34930465 http://dx.doi.org/10.1186/s40246-021-00372-x |
_version_ | 1784617978896056320 |
---|---|
author | Zhu, Ke Xiaoqiang, Liu Deng, Wen Wang, Gongxian Fu, Bin |
author_facet | Zhu, Ke Xiaoqiang, Liu Deng, Wen Wang, Gongxian Fu, Bin |
author_sort | Zhu, Ke |
collection | PubMed |
description | BACKGROUND: The unfolded protein response (UPR) served as a vital role in the progression of tumors, but the molecule mechanisms of UPR in bladder cancer (BLCA) have been not fully investigated. METHODS: We identified differentially expressed unfolded protein response-related genes (UPRRGs) between BLCA samples and normal bladder samples in the Cancer Genome Atlas (TCGA) database. Univariate Cox analysis and the least absolute shrinkage and selection operator penalized Cox regression analysis were used to construct a prognostic signature in the TCGA set. We implemented the validation of the prognostic signature in GSE13507 from the Gene Expression Omnibus database. The ESTIMATE, CIBERSORT, and ssGSEA algorithms were used to explore the correlation between the prognostic signature and immune cells infiltration as well as key immune checkpoints (PD-1, PD-L1, CTLA-4, and HAVCR2). GDSC database analyses were conducted to investigate the chemotherapy sensitivity among different groups. GSEA analysis was used to explore the potential mechanisms of UPR-based signature. RESULTS: A prognostic signature comprising of seven genes (CALR, CRYAB, DNAJB4, KDELR3, CREB3L3, HSPB6, and FBXO6) was constructed to predict the outcome of BLCA. Based on the UPRRGs signature, the patients with BLCA could be classified into low-risk groups and high-risk groups. Patients with BLCA in the low-risk groups showed the more favorable outcomes than those in the high-risk groups, which was verified in GSE13507 set. This signature could serve as an autocephalous prognostic factor in BLCA. A nomogram based on risk score and clinical characteristics was established to predict the over survival of BLCA patients. Furthermore, the signature was closely related to immune checkpoints (PD-L1, CTLA-4, and HAVCR2) and immune cells infiltration including CD8(+) T cells, follicular helper T cells, activated dendritic cells, and M2 macrophages. GSEA analysis indicated that immune and carcinogenic pathways were enriched in high-risk group. CONCLUSIONS: We identified a novel unfolded protein response-related gene signature which could predict the over survival, immune microenvironment, and chemotherapy response of patients with bladder cancer. |
format | Online Article Text |
id | pubmed-8686253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86862532021-12-20 Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer Zhu, Ke Xiaoqiang, Liu Deng, Wen Wang, Gongxian Fu, Bin Hum Genomics Primary Research BACKGROUND: The unfolded protein response (UPR) served as a vital role in the progression of tumors, but the molecule mechanisms of UPR in bladder cancer (BLCA) have been not fully investigated. METHODS: We identified differentially expressed unfolded protein response-related genes (UPRRGs) between BLCA samples and normal bladder samples in the Cancer Genome Atlas (TCGA) database. Univariate Cox analysis and the least absolute shrinkage and selection operator penalized Cox regression analysis were used to construct a prognostic signature in the TCGA set. We implemented the validation of the prognostic signature in GSE13507 from the Gene Expression Omnibus database. The ESTIMATE, CIBERSORT, and ssGSEA algorithms were used to explore the correlation between the prognostic signature and immune cells infiltration as well as key immune checkpoints (PD-1, PD-L1, CTLA-4, and HAVCR2). GDSC database analyses were conducted to investigate the chemotherapy sensitivity among different groups. GSEA analysis was used to explore the potential mechanisms of UPR-based signature. RESULTS: A prognostic signature comprising of seven genes (CALR, CRYAB, DNAJB4, KDELR3, CREB3L3, HSPB6, and FBXO6) was constructed to predict the outcome of BLCA. Based on the UPRRGs signature, the patients with BLCA could be classified into low-risk groups and high-risk groups. Patients with BLCA in the low-risk groups showed the more favorable outcomes than those in the high-risk groups, which was verified in GSE13507 set. This signature could serve as an autocephalous prognostic factor in BLCA. A nomogram based on risk score and clinical characteristics was established to predict the over survival of BLCA patients. Furthermore, the signature was closely related to immune checkpoints (PD-L1, CTLA-4, and HAVCR2) and immune cells infiltration including CD8(+) T cells, follicular helper T cells, activated dendritic cells, and M2 macrophages. GSEA analysis indicated that immune and carcinogenic pathways were enriched in high-risk group. CONCLUSIONS: We identified a novel unfolded protein response-related gene signature which could predict the over survival, immune microenvironment, and chemotherapy response of patients with bladder cancer. BioMed Central 2021-12-20 /pmc/articles/PMC8686253/ /pubmed/34930465 http://dx.doi.org/10.1186/s40246-021-00372-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Zhu, Ke Xiaoqiang, Liu Deng, Wen Wang, Gongxian Fu, Bin Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer |
title | Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer |
title_full | Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer |
title_fullStr | Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer |
title_full_unstemmed | Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer |
title_short | Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer |
title_sort | identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686253/ https://www.ncbi.nlm.nih.gov/pubmed/34930465 http://dx.doi.org/10.1186/s40246-021-00372-x |
work_keys_str_mv | AT zhuke identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer AT xiaoqiangliu identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer AT dengwen identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer AT wanggongxian identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer AT fubin identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer |